Live Breaking News & Updates on Lung Cancer Biomarkers

Stay updated with breaking news from Lung cancer biomarkers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Worldwide Immuno-Oncology Assays Industry is Projected to Reach $7.9 Billion by 2026 at a CAGR of 12.5% from 2021


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period.
Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market.
The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product & service, during the forecast period ....

United States , Merck Millipore , Asia Pacific , Technologietransfer Gmb , Laura Wood , Software Services , Nanostring Technologies Inc , Dynamic Companies , Meso Scale Diagnostics , Guardant Health Inc , Progressive Companies , Seegene Inc , Htg Molecular Diagnostics Inc , Porter Five Forces Analysis , Roche Ltd , Invivoscribe Inc , Abbott Laboratories Inc , Office Hours Call , Research Methodology , Asuragen Inc , Product Service , Technology Analysis , Thermo Fisher Scientific Inc , Agilent Technologies Inc , Company Evaluation Quadrant , Perkinelmer Inc ,